|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Guidelines for the Prevention and Treatment of Chronic Hepatitis B(version 2022)显示文摘To facilitate the achieving of the goal of“eliminating viral hepatitis as a major public health threat by 2030”set by the World Health Organization,the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases(both are branches of the Chinese Medical Association)organized a panel of experts and updated the guidelines for prevention and treatment of chronic hepatitis B in China(version 2022).With the support of available evidence,this revision of the guidelines focuses on active prevention,large scale testing,and expansion of therapeutic indication of chronic hepatitis B with the aim of reducing the hepatitis B related disease burden. | Hong You Fusheng Wang Taisheng Li Xiaoyuan Xu Yameng Sun Yuemin Nan Guiqiang Wang Jinlin Hou Zhongping Duan Lai Wei Jidong Jia Hui Zhuang Chinese Society of Hepatology,Chinese Medical Association Chinese Society of Infectious Diseases,Chinese Medical Association | 2023 | Journal of Clinical and Translational Hepatology2023，11，6： | 5 |
| 2 | Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)显示文摘In 2015, the Chinese Society of Hepatology and the Chinese Society of Gastroenterology published a consensus on pri-mary biliary cholangitis (PBC). In the past years, numerous clinical studies have been published in the field of PBC. To guide the clinical diagnosis and management of PBC patients, the Chinese Society of Hepatology invited a panel of experts to assess the new clinical evidence and formulate the current guidelines. | Hong You Weijia Duan Shuxiang Li Tingting Lv Sha Chen Lungen Lu Xiong Ma Ying Han Yuemin Nan Xiaoyuan Xu Zhongping Duan Lai Wei Jidong Jia Hui Zhuang Chinese Society of Hepatology,Chinese Medical Association | 2023 | Journal of Clinical and Translational Hepatology2023，11，3： | 1 |
| 3 | Guidelines for the Prevention and Treatment of Chronic Hepatitis B(Version 2022)显示文摘To facilitate the achieving of the goal of“eliminating viral hepatitis as a major public health threat by 2030”set by theWorld Health Organization,the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases(both are branches of the ChineseMedical Association)organized a panel of experts and updated the guidelines for prevention and treatment of chronic hepatitis B in China(version 2022).With the support of available evidence,this revision of the guidelines focuses on active prevention,large-scale testing,and expansion of therapeutic indication of chronic hepatitis B with the aim of reducing the hepatitis B–related disease burden. | Hong You Fu-Sheng Wang Taisheng Li Xiaoyuan Xu Yameng Sun Yuemin Nan Guiqiang Wang Jinlin Hou Zhongping Duan Lai Wei Jidong Jia Hui Zhuang Chinese Society of Hepatology,Chinese Medical Association Chinese Society of Infectious Diseases,Chinese Medical Association | 2023 | Infectious Diseases & Immunity2023，3，4： | 0 |
| 4 | Clinical characteristics and possible etiology in children with acute severe hepatitis of unknown etiology显示文摘To the Editor:According to the data released by the World Health Organization(WHO)on July 12,2022,around 1010 cases of children with acute hepatitis of unknown etiology have been reported in five regions and 35 countries globally;these reports include new and retrospectively identified cases since October 1,2021.Most patients presented with acute severe hepatitis and significantly high transaminase levels;the most common symptoms and signs were nausea or vomiting(60%). | Jie Li Xinyu Hu Xuebing Yan Chao Wu Yuemin Nan | 2022 | Chinese Medical Journal2022，135，24： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员